Chong Kun Dang Pharmaceutical Corp
KRX:185750
Wall Street
Price Targets
Price Targets Summary
Chong Kun Dang Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for Chong Kun Dang Pharmaceutical Corp is 142 216.08 KRW with a low forecast of 101 000.01 KRW and a high forecast of 168 000 KRW.
Operating Income
Forecast
Operating Income Estimate
Chong Kun Dang Pharmaceutical Corp
For the last 8 years the compound annual growth rate for Chong Kun Dang Pharmaceutical Corp's operating income is 25%. The projected CAGR for the next 3 years is -18%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Chong Kun Dang Pharmaceutical Corp's stock price target?
Price Target
142 216.08
KRW
According to Wall Street analysts, the average 1-year price target for Chong Kun Dang Pharmaceutical Corp is 142 216.08 KRW with a low forecast of 101 000.01 KRW and a high forecast of 168 000 KRW.
What is Chong Kun Dang Pharmaceutical Corp's Revenue forecast?
Projected CAGR
2%
For the last 8 years the compound annual growth rate for Chong Kun Dang Pharmaceutical Corp's revenue is 14%. The projected CAGR for the next 3 years is 2%.
What is Chong Kun Dang Pharmaceutical Corp's Operating Income forecast?
Projected CAGR
-18%
For the last 8 years the compound annual growth rate for Chong Kun Dang Pharmaceutical Corp's operating income is 25%. The projected CAGR for the next 3 years is -18%.
What is Chong Kun Dang Pharmaceutical Corp's Net Income forecast?
Projected CAGR
-19%
The compound annual growth rate of Chong Kun Dang Pharmaceutical Corp's net income for the next 3 years is -19%.